Recent findings demonstrated that, through phosphorylation of STAT3, syntenin-1 increases the expression of PD-L1 in both breast cancer cell lines and in tumor tissues derived from patients with TNBC cocultured with T CD8+ cells. Here, SDCBP is linked to breast carcinoma.